Introduction
To understand mechanisms underlying craniofacial birth defects [1] [2] , important tissues and their signaling contributions during craniofacial development must be identified. In the frog Xenopus laevis, part of the face, including the mouth and nostrils form from the "Extreme Anterior Domain" (EAD), where ectoderm and endoderm are directly juxtaposed [3] [4] . The EAD also acts as a signaling center to influence surrounding tissues, including the cranial neural crest, which forms the jaws and other facial regions 5 . To identify genes that contribute to EAD function, a 'face transplant' technique was developed, where tissue is transplanted from a donor into a host embryo, after removing the corresponding host region. Following the transplant, resulting facial development is assessed. Thus, the effects of loss of function (LOF) or gain of function (GOF) for a specific gene in the EAD are analyzed locally, where the rest of the head and body is composed of wild type tissue. The reciprocal transplant can be performed, where wild type tissue is transplanted into embryos with global LOF or GOF in specific genes. Transplantation has been frequently used in Xenopus and chick studies 6 . For example, Xenopus transplantation has addressed homogenetic neural induction, lens and neural competence, and neural crest migration [7] [8] [9] [10] . Quail-chick chimeric grafting has analyzed development of the anterior neural plate, anterior neural ridge, neural crest, and cranial bones [11] [12] [13] [14] . This is the first transplant technique for study of craniofacial development in Xenopus. This technique has demonstrated a novel role for the Wnt inhibitors Frzb1 and Crescent in regulating basement membrane formation in the presumptive mouth 5 . Xenopus laevis is an ideal model for study of craniofacial development as embryos are large, develop externally, and the face is readily visible, allowing micromanipulation and imaging of development. Mechanisms underlying facial development appear conserved, indicating that findings made in the frog provide insight into human development 4, [15] [16] .
Preparing Glass Operating Tools
1. Needle preparation: Load capillary tubing into a needle puller.
1. Pull the needles according to the settings shown in Table 2 : Needle puller settings. The settings are for a Sutter Instrument Co. Model P-80/PC micropipette puller and capillary tubings, as described in the Table of specific reagents and equipment. However, these settings are specific to the Sutter needle puller, and will need to be adjusted for other machines. Settings can be determined using a ramp test, as specified by the machine's manufacturer. 2. Pull 4-6 needles in preparation for the procedure. The needles should be broken such that the flexible, hair-like portion of the glass tip is fully removed, which is typically 2-3 mm long. The tip must be relatively rigid, but still narrow enough to be used as a cutting tool. See photo of an ideal needle in Figure 1A . 3 . Store the needles in a Petri dish with a strip of clay down the center. Press the shaft of each needle into the clay, to hold it in place and to keep the fragile sharp tip away from the bottom and sides.
2. For additional tools, obtain glass cover slips, a pair of long standard pattern forceps, a Bunsen burner, and 3-4 glass Pasteur pipettes (Size 5 ¾ in). 3. Pipette tool: To make a pipette tool, light the Bunsen burner and place the tip of a glass Pasteur pipette into the blue part of the flame while rotating it, such that the tip melts and the hole completely seals, forming a closed, rounded end. The rounded, sealed tip is later used to make depressions in the clay dish that holds the embryos during the operation. See Figure 1B . 4. Glass bridges: To make glass bridges, use long standard pattern forceps to carefully break off 3 mm by 3 mm chunks of cover slip glass.
While holding the piece of cover slip with tweezers, place the glass in the flame until all four edges soften and curve downward, forming a tiny glass dome. The edges should no longer be sharp. See Figure 1C . 5. Store the glass cover slip bridges by inserting them, edges down, into modeling clay, lining the bottom of a Petri dish. Insert the bridges such that the top of the bridge remains above the clay surface. Do not push too hard such that the bridge breaks, and do not fully embed the bridge into the clay, because it can be difficult to remove. After sterilization with a flame or 70% ethanol, the bridges can be reused from experiment to experiment.
Preparing for the Embryo Operation
1. Line a small 60 mm plastic Petri dish with modeling clay. Between uses, the dish and clay surface is thoroughly washed with distilled water and then with 70% ethanol.
NOTE: Use red, white or yellow, Van Aken Plastalina modeling clay, which can be bought at a local toy or art store. Black clay is not recommended because it releases a residue. 2. Fill the dish with 3% Ficoll 0.5x MBS solution. The higher salt concentration prevents tissue dissociation, and the polysaccharide Ficoll helps to thicken the solution, which assists in holding the face in position. 3. Use the flamed Pasteur pipette tool (see Figure 1 ) to make shallow, 2-3 mm depressions in the clay, about the depth of a stage 20 embryo body. Make 20-30 depressions, 1-2 mm apart, on each side of the dish, so there is a total of 40-60 depressions. Label one side LOF/GOF, and the other side wild type, by carving initials into the clay with forceps.
Preoperation Embryo Preparation
1. Obtain and culture Xenopus laevis embryos using standard methods 17 . For a detailed description of frog husbandry, please see Sive et al. 17 1. Forty-eight hours prior to the experiment obtain eggs from female frogs and perform in vitro fertilization. 2. Inject 0.5-1 ng of capped membrane GFP mRNA, plus any desired mRNA or anti-sense morpholino-modified antisense oligonucleotides ("morpholinos") at the one cell stage or into 2 cells at the 2 cell stage. The one cell stage lasts approximately 70-90 min. Inject a total volume of 1-3 nl. In place of RNA coding for a fluorescent protein (such as GFP or RFP RNA), one can inject FITC labeled morpholino or fluorescently labeled dextran. The fluorescence is important for determining whether the transplanted tissue heals and remains in the head. 3. Capped mRNA can be prepared from a linearized plasmid using a mMessage mMachine SP6 or T7 kit. Morpholinos can be designed and ordered through Gene Tools LLC. NOTE: On the day of the surgery, both recipient and donor embryos must be within one stage of each other for the transplants to work optimally. However, embryos injected with morpholinos ("morphants") sometimes develop more slowly than wild type or control morphant embryos, making it necessary to coordinate experiments so both morphant and wild type embryos are at the same stage.
Morphants may need to be maintained at a higher temperature for 12-24 hr prior to the procedure. To increase the likelihood that embryos can be found at matching stages, embryos can be maintained at several temperatures. Twenty-four hours prior to the experiment, one should divide the embryos into a several dishes, and place morphants at 18-20 °C and wild type embryos at 15-18 °C.
2. On the day of the transplantation experiment, remove the embryos from the15 °C incubator and stage them according to Nieuwkoop 6 . Move host embryos into the operating dish using a plastic graduated transfer pipette with the tip cut off such that the opening is much wider than an embryo (at least a few millimeters). Be careful to avoid touching embryos to bubbles or the water surface, as embryos will explode in the surface tension. 7. Use #5/45 forceps to insert the embryos into the clay depressions, with the posterior of the embryo in the clay. Gently close the clay around the bases of the embryo using the forceps, leaving the top quarter of the embryo, the head, protruding from the depression. 8. Once all host embryos are secured in their depressions, move to the other side of the plate and begin to insert the donor embryos into their depressions. Repeat the process of securing the embryos in their wells. Gently push the excised tissue on the tip of the needle, and lift it through the buffer to the part of the dish containing host embryos. Do not expose the tissue to the surface air or it will become damaged. 7. Excise the same tissue from the host embryo, as for the donor. Discard the host EAD explant or save it to insert into the donor face, for reciprocal transplants. 8. Insert the donor explant into the resulting host hole using #5/45 forceps. 9. Once the donor tissue is correctly positioned and fully inserted, carefully place a glass bridge (see Figure 1 and Figure 2Bc ) over the embryo's face to hold the transplant in place. The ends of the bridge should insert into the clay, holding it in place. The bridge should gently apply pressure to the transplanted tissue, such that the transplant lies flush with the host head, without it sticking out of the head or lying deep within the head. The head can be slightly flattened by the cover slip, but be careful not to damage the embryo with too much pressure. Transplants should be performed within 5 minutes.
Performing the Face Transplant Surgery
NOTE: An experienced investigator can perform around twenty transplants per experiment, over 2-3 hr. During this period the embryos will progress from stage 20-22. Completing the face transplants at stage 21 or 22 does not affect outcomes. Later transplants (at stages 22-26) can be done but are more difficult as the crest-free EAD midline region is narrowed as cranial neural crest moves into the face. Consistency across transplants is critical.
Face Transplant Post-operation Recovery
1. Healing typically takes 2-3 hr. Leave the embryos at room temperature undisturbed in their clay depressions with the glass bridges holding the donor tissue in place. 2. Once the transplants have healed, carefully remove the glass bridges, remove the clay from around the base of the embryos using forceps, and use a plastic graduated transfer pipette to gently vacuum the embryos out of their depressions. 3. Put the embryos into an appropriately labeled Petri dish, half filled with clean 0.1x MBS with gentamycin. 4. Grow the embryos at 15 °C or 18 °C for several days until they reach feeding tadpole stage at stage 40, when facial phenotypes can be scored. 1. The 0.1x MBS solution with gentamycin should be changed daily, and any dead embryos should be removed promptly to prevent contamination and death of other embryos.
Representative Results
Transplanted tissue should be fully inserted into the host head after transplantation as shown in Figure 3A , and have a glass bridge appropriately placed on the embryo's face, as shown in Figure 2Bc . The transplanted donor tissue must be correctly sized for the host opening, for the transplant to be successful. The EAD tissue should not protrude from the head, in any way, as seen in Figures 3B and 3C. Additionally, the face transplant should not be rotated relative to its position in the donor body, as shown in Figure 3D . After several hours, the transplanted tissue and surrounding face should heal, and by the next day, the embryo should appear as the example shown in Figures 4A and 4A' . One can observe, under fluorescence, that the transplant remains in place in Figure 4B . At stage 41, the transplanted control tissue will contribute to the mouth, and will remain florescent green, seen in Figure 4B '. Wild type EAD tissue transplanted into wild type hosts should give rise to normal faces, when compared with unperturbed wild type embryos. However, with LOF or GOF donor tissue, faces should heal and remain in the head, but these may or may not give rise to normal craniofacial structures, as shown in *Needle puller settings vary from machine to machine so each lab will probably need to optimize their own needle puller settings. The donor face tissue should not be rotated in the host body relative to its original position in the donor embryo, otherwise the face will not develop normally. The cement gland does not need to be included in the face transplant for the procedure to work; the face develops normally without it. However, the cement gland is often included in the extirpated facial tissue because it serves as a distinct marker to indicate and position the bottom of the transplant. This marker will help avoid accidently rotating the tissue during the transfer of the face tissue to the recipient. If the transplant has been inserted incorrectly in the host face, the donor tissue can be removed and discarded. One can attempt to insert a new transplant into the same host, if the opening has not begun to constrict. However, if the host opening has noticeably shrunk, then discard the host and begin anew.
It is crucial to place the glass bridge directly on the transplanted face, so that the transplant is held in the host's head during healing. If the transplant is not held in place, the transplant can be extruded from host's face. Transplants that are not fully inserted into the face or that pop out during healing will undergo necrosis. Even in perfect transplants, small amounts of tissue death may occur around the edges of the transplant. Usually this does not cause adverse effects and a completely normal face can still be formed. In successful controls we have not observed any malformation after four weeks of development suggesting that the cartilages formed normally and that rejection of the tissue is rare.
Finally, if a morpholino perturbs a protein required for normal wound healing, this technique may not work, as the transplanted LOF tissue may not be incorporated into the host head.
Possible Modifications and Trouble Shooting: Modifications can be made to the procedure. With practice, the researcher can learn to transplant smaller regions, for example, half of the EAD. Shallow incisions allow ectodermal transplants, leaving the deeper endoderm undisturbed. Other regions of embryonic tissue can be transplanted, using similar approaches.
If the transplanted tissue dies after insertion, there are a couple of possible causes. Transplanted tissue that is not completely inserted into the host or appropriately held in place with a glass bridge, will die and impede proper healing. Make sure to fully insert the transplanted tissue and secure it in place with a glass bridge. If the transplant is derived from a morpholino or RNA injected donor, then the tissue may die due to toxicity from injected agents. Similarly, if the host embryos are morphants or RNA-injected and frequently die, then the amount of morpholino or RNA will need to be reduced. To resolve these issues, titrate the amount of injected RNA or morpholino and determine a safe amount for successful face transplants. Finally, increasing the salt concentration of the MBS solution above 0.1x can also assist healing.
Significance: The face transplant technique described allows analysis of the local requirements and activity of gene products during craniofacial development. This approach can clarify signaling between the developing noncrest, neural crest, and surrounding structures. It allows one to examine LOF or GOF (using any strategy) in all EAD-derived tissues, which is not possible with any single promoter driven construct. Though there is a long history of tissue transplantation in developmental biology this is the first application of transplantation to the study of craniofacial development in frogs and is crucial for mechanistic studies 7 . Thus the technique can help to unravel the complex mechanisms controlling patterning and formation of the vertebrate face and to clarify causes of craniofacial developmental defects.
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